Osteoporosis: An Age-Related and Gender-Specific Disease – A Mini-ReviewPietschmann P.a, b · Rauner M.b, c · Sipos W.d · Kerschan-Schindl K.e
aDepartment of Pathophysiology, Center for Physiology, Pathophysiology and Immunology, Medical University of Vienna, and bLudwig Boltzmann-Institute of Aging Research, Vienna, Austria; cDivision of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, Technical University, Dresden, Germany; d2nd Medical Clinic, University of Veterinary Medicine Vienna, and eDepartment of Physical Medicine and Rehabilitation, Medical University of Vienna, Vienna, Austria
Dr. Peter Pietschmann, MD
Department of Pathophysiology, Center of Physiology and Pathophysiology
Medical University of Vienna, Währinger Gürtel 18–20, AT–1090 Vienna (Austria)
Tel. +43 140 400 5122, Fax +43 140 400 5130
Do you have an account?
Osteoporosis, a classical age-related disease and known to be more common in women than in men, has been reported increasingly often in men during the past few years. Although men at all ages after puberty have larger bones than women, resulting in greater bending strength, mortality after a hip fracture, one of the major complications of osteoporosis, is more common in men than in women. Sex hormone deficiency is associated with unrestrained osteoclast activity and bone loss. Even though estrogen deficiency is more pronounced in women, it appears to be a major factor in the pathogenesis of osteoporosis in both genders. In contrast to osteoporosis in postmenopausal women, the treatment of osteoporosis in men has been scarcely reported. Nevertheless, some drugs commonly used for the treatment of osteoporosis in women also appear to be effective in men. The aim of this study is to review primary osteoporosis in the elderly with particular emphasis on gender-related aspects.
© 2008 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.